https://www.selleckchem.com/pr....oducts/bzatp-triethy
A total of 818 eligible patients received one or more lines of salvage therapy, 809 received second-line salvage therapy, and 397 received third-line salvage therapy. Complete remission rates decreased from 14% after first salvage therapy to 9% after second salvage therapy and 3% after third salvage therapy. Median overall survival was 6.30, 4.07, and 2.98 months after first, second, and third salvage therapies, respectively. These data indicate that the best chance of obtaining long-term remission in AML is with a s
Like
Comment
Share
